Zavget 5mg Tablet – Once-Daily Gentle-Start SGLT2 Inhibitor
Zavget 5mg Tablet – Once-Daily Gentle-Start SGLT2 Inhibitor
Zavget 5mg Tablet – Once-Daily Gentle-Start SGLT2 Inhibitor
Description
Zavget 5mg Tablet – Dapagliflozin 5mg Perfect Entry-Level Dose for New Patients & Sensitive Profiles
Zavget 5mg is the proven lower-strength starter dose of dapagliflozin – the world’s most-researched SGLT2 inhibitor – specially designed for people beginning therapy, the elderly, those with mild kidney impairment, or anyone who prefers a smoother introduction while still receiving the complete cardiovascular and renal protective benefits demonstrated in the landmark DECLARE, DAPA-HF and DAPA-CKD trials. A single 5mg morning tablet gently removes excess glucose, promotes modest steady weight reduction (2–4 kg), lowers blood pressure naturally, and delivers the same magnitude of life-saving heart-failure and kidney-protection outcomes as the higher 10mg strength.
